Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial-Reference-Cited by-同舟云学术

Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial

Published:2017-09 Issue:9 Volume:18 Page:1249-1260
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Alderson Derek,Cunningham David,Nankivell Matthew,Blazeby Jane M,Griffin S Michael,Crellin Adrian,Grabsch Heike I,Langer Rupert,Pritchard Susan,Okines Alicia,Krysztopik Richard,Coxon Fareeda,Thompson Joyce,Falk Stephen,Robb Clare,Stenning Sally,Langley Ruth E

Funder

Cancer Research UK

Publisher

Elsevier BV

Subject

Oncology

Reference42 articles.

1. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis;Sjoquist;Lancet Oncol,2011

2. Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data;Ronellenfitsch;Eur J Cancer,2013

3. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer;Nygaard;World J Surg,1992

4. A prospective study of combined therapy in esophageal cancer;Apinop;Hepatogastroenterology,1994

5. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus;Le Prise;Cancer,1994

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety, and survival of neoadjuvant immunotherapy plus chemotherapy in locally advanced esophageal squamous cell carcinoma: A real-world retrospective study;International Immunopharmacology;2024-09

2. Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction;JAMA Network Open;2024-08-02

3. Navigating complexities and considerations for suspected anastomotic leakage in the upper gastrointestinal tract: A state of the art review;Best Practice & Research Clinical Gastroenterology;2024-06

4. Development of perioperative immune checkpoint inhibitor therapy for locally advanced esophageal squamous cell carcinoma;Future Oncology;2024-05-17

5. Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study;Cancers;2024-03-31